Aristeia Capital, LLC
+3.11%
3M Return
$16.200
-0.178 (-1.10%)終値時点
WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.
WW International Inc is currently priced at $16.20, which is below the analyst price target of $20, indicating potential upside. However, the forward P/E ratio is significantly high at 74.07, suggesting that the stock may be overvalued relative to its earnings potential. Additionally, the company has experienced a substantial year-to-date decline of 48.47%, which raises concerns about its stability. The recent positive earnings surprise of 58.43% and a gross margin of 70.32% in Q2 2026 are encouraging signs, but the overall financial performance remains inconsistent, with net income fluctuations and a negative net margin of -30.90% in Q1 2026. Therefore, while there are some positive indicators, the high valuation and recent performance trends suggest a cautious approach is warranted.

WW (WW) Q2 2026 Earnings Call Transcript

Sam's Club Partners with Weight Watchers for Wellness Initiative

WW International Q2 2026 Earnings Call Insights

Weight Watchers Partners with AHA for Healthy Living BEYOND Weight Study

WW (WW) Q4 2025 Earnings Call Transcript
WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools. It operates in the Consumer Non-Cyclicals sector (SERVICES-PERSONAL SERVICES industry).
WW International Inc is currently priced at $16.20, which is below the analyst price target of $20, indicating potential upside. However, the forward P/E ratio is significantly high at 74.07, suggesting that the stock may be overvalued relative to its earnings potential. Additionally, the company has experienced a substantial year-to-date decline of 48.47%, which raises concerns about its stability. The recent positive earnings surprise of 58.43% and a gross margin of 70.32% in Q2 2026 are encouraging signs, but the overall financial performance remains inconsistent, with net income fluctuations and a negative net margin of -30.90% in Q1 2026. Therefore, while there are some positive indicators, the high valuation and recent performance trends suggest a cautious approach is warranted.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。